Bio-Path Holdings, Inc.
BPTH
$0.14
-$0.005-3.45%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.91% | 0.98% | -10.33% | -9.19% | -10.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.31% | -26.17% | -23.58% | -10.03% | 13.97% |
| Operating Income | 24.31% | 26.17% | 23.58% | 10.03% | -13.97% |
| Income Before Tax | 38.46% | 36.94% | 31.81% | 11.53% | -15.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.46% | 36.94% | 31.81% | 11.53% | -15.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.46% | 36.94% | 31.81% | 11.53% | -15.94% |
| EBIT | 24.31% | 26.17% | 23.58% | 10.03% | -13.97% |
| EBITDA | 24.25% | 26.08% | 23.57% | 10.05% | -14.10% |
| EPS Basic | 79.36% | 69.87% | 59.45% | 34.67% | 6.03% |
| Normalized Basic EPS | 79.36% | 69.87% | 59.45% | 34.67% | 6.03% |
| EPS Diluted | 79.36% | 69.89% | 59.47% | 34.70% | 6.12% |
| Normalized Diluted EPS | 79.36% | 69.87% | 59.45% | 34.67% | 6.03% |
| Average Basic Shares Outstanding | 401.62% | 250.33% | 119.73% | 44.45% | 31.32% |
| Average Diluted Shares Outstanding | 401.62% | 250.33% | 119.73% | 44.45% | 31.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |